Biogen CEO Confident in Current Pipeline, No Urgent Need for Acquisitions

Biogen CEO Confident in Current Pipeline, No Urgent Need for Acquisitions

Biogen’s CEO believes the company’s future relies on its existing products, not new acquisitions, despite market pressures and recent challenges. Biogen CEO Confident in Current Pipeline, No Urgent Need for Acquisitions San Francisco: So, Biogen’s CEO, Chris Viehbacher, recently shared some thoughts at the JP Morgan Healthcare Conference. He’s pretty optimistic about the company’s future,…

Sage Therapeutics, Inc. Stock News and Insights on Yahoo Finance

Sage Therapeutics, Inc. Stock News and Insights on Yahoo Finance

Sage Therapeutics focuses on brain health medicines, including treatments for depression and essential tremors, with ongoing clinical trials. Sage Therapeutics, Inc. Stock News and Insights on Yahoo Finance Cambridge: So, Sage Therapeutics is making waves in the biopharmaceutical world. They’re all about brain health and have some cool products in the pipeline. One of their…